Cargando…

Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer

PURPOSE: The molecular drivers of metastasis in breast cancer are not well understood. Therefore, we sought to identify the biological processes underlying distant progression and define a prognostic signature for metastatic potential in breast cancer. EXPERIMENTAL DESIGN: In vivo screening for meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Shuang G., Shilkrut, Mark, Speers, Corey, Liu, Meilan, Wilder-Romans, Kari, Lawrence, Theodore S., Pierce, Lori J., Feng, Felix Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431866/ https://www.ncbi.nlm.nih.gov/pubmed/25974184 http://dx.doi.org/10.1371/journal.pone.0126631

Ejemplares similares

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Speers, Corey, et al.
Publicado: (2017)

Molecular Signatures of Radiation Response in Breast Cancer: Towards Personalized Decision-Making in Radiation Treatment
por: Speers, Corey, et al.
Publicado: (2017)

RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes
por: Pesch, Andrea M., et al.
Publicado: (2022)

Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
por: Pesch, Andrea M., et al.
Publicado: (2022)

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)

ARe we there yet? Understanding androgen receptor signaling in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
por: Niknafs, Yashar S., et al.
Publicado: (2016)

Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer
por: Sjöström, Martin, et al.
Publicado: (2023)

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
por: Sjöström, Martin, et al.
Publicado: (2019)

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment
por: Kregel, Steven, et al.
Publicado: (2020)

Gene signatures of breast cancer progression and metastasis
por: Rodenhiser, David I, et al.
Publicado: (2011)

Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer
por: Jungles, Kassidy M., et al.
Publicado: (2022)

A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity
por: Chandler, Benjamin C., et al.
Publicado: (2020)

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
por: Stenmark Tullberg, Axel, et al.
Publicado: (2023)

Estrogen receptor mutations and their role in breast cancer progression
por: Alluri, Prasanna G, et al.
Publicado: (2014)

General Commentary to the “Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer” by Darwish O. M. and Raj G. V.
por: Shilkrut, Mark, et al.
Publicado: (2012)

Biomimetic Microfluidic Platforms for the Assessment of Breast Cancer Metastasis
por: Sigdel, Indira, et al.
Publicado: (2021)

Multi-Platform Whole-Genome Microarray Analyses Refine the Epigenetic Signature of Breast Cancer Metastasis with Gene Expression and Copy Number
por: Andrews, Joseph, et al.
Publicado: (2010)

DDRE-28. MECHANISTIC AND THERAPEUTIC LINKS BETWEEN PURINE BIOSYNTHESIS AND DNA DAMAGE IN GLIOBLASTOMA
por: Scott, Andrew, et al.
Publicado: (2021)

Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells
por: Zhou, Xiaochen, et al.
Publicado: (2020)

Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
por: Goeman, Frauke, et al.
Publicado: (2020)

Independent and functional validation of a multi-tumour-type proliferation signature
por: Starmans, M H W, et al.
Publicado: (2012)

A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
por: Jackson, William C, et al.
Publicado: (2013)

Cross-platform comparison of independent datasets identifies an immune signature associated with improved survival in metastatic melanoma
por: Lardone, Ricardo D., et al.
Publicado: (2016)

Platform-independent gene expression signature differentiates sessile serrated adenomas/polyps and hyperplastic polyps of the colon
por: Rahmatallah, Yasir, et al.
Publicado: (2017)

MINT: a multivariate integrative method to identify reproducible molecular signatures across independent experiments and platforms
por: Rohart, Florian, et al.
Publicado: (2017)

Degrading AR-Dependent Cancers: Expanding the Role of PROTACs
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Evaluation of data discretization methods to derive platform independent isoform expression signatures for multi-class tumor subtyping
por: Jung, Segun, et al.
Publicado: (2015)

D91. Effect of Pre-pectoral Versus Sub-pectoral Implant Placement in Breast Reconstruction on the Delivery of Post-mastectomy Radiation
por: Baglien, Brigit D., et al.
Publicado: (2023)

Cross-platform validation of a mouse blood gene signature for quantitative reconstruction of radiation dose
por: Ghandhi, Shanaz A., et al.
Publicado: (2022)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
por: Zhang, Zhao, et al.
Publicado: (2022)

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021)

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms
por: Peck, Amy R, et al.
Publicado: (2016)

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012)

A novel gene expression signature for bone metastasis in breast carcinomas
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pug6asrrs41t0i4q7rvgk6duns